Biotech firms Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies are joining the International Society for Cellular Therapy (ISCT) to launch a series of initiatives to create greater strategic alignment within the industry and drive late stage clinical development.
Established in 1992, ISCT works to foster international translational research; inform national and global regulatory framework development and harmonization;...